Browsing: HanchorBio Inc

HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101

By Marie JonesOctober 3, 20230

HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide…

BioTech

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

By Marie JonesAugust 28, 20230

HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech,…

BioTech

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

By Marie JonesJuly 24, 20230

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA HanchorBio Inc., a global clinical-stage biotechnology company developing…

BioTech

HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

By Marie JonesApril 17, 20230

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA HanchorBio Inc., a global clinical-stage biotechnology company developing…